WELLINGTON-ALTUS USA INC.’s PDL BioPharma, Inc. PDLI Stock Holding History

WELLINGTON-ALTUS USA INC.’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$0	Hold	275	–	–	﹤0.01%	722
2026 Q1	$0	Hold	275	–	–	﹤0.01%	760
2025 Q4	$0	Buy	+275	New	–	﹤0.01%	669

Other funds holding PDLI

Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return

WELLINGTON-ALTUS USA INC.'s PDLI Position: Q2 2026 in Review

WELLINGTON-ALTUS USA INC. held its PDL BioPharma, Inc. (PDLI) position steady in Q2 2026 at 275 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #722.

WELLINGTON-ALTUS USA INC. first reported a position in PDLI in Q4 2025 and has held it in 3 quarters since. 6 funds tracked by Wall St. Rank hold PDLI as of Q2 2026.

WELLINGTON-ALTUS USA INC. held 275 shares of PDL BioPharma, Inc. worth $0 as of Q2 2026.
WELLINGTON-ALTUS USA INC. left its PDL BioPharma, Inc. share count unchanged in Q2 2026.
PDL BioPharma, Inc. made up ﹤0.01% of WELLINGTON-ALTUS USA INC.'s portfolio in Q2 2026, its #722 holding.
WELLINGTON-ALTUS USA INC. first reported a position in PDL BioPharma, Inc. in Q4 2025 and has held it in 3 quarters since.
6 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q2 2026.

Based on WELLINGTON-ALTUS USA INC.'s 13F filing for Q2 2026, filed 17 Sep 2026.